NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Cencora, Inc. COR | NYSE

$300.40 -$7.20 | -2.34%
SIGNAL:Signal available — unlock to view |2026-09-18 |F&G 34 |RSI 36.3

Company Overview:

Market Cap: $57.32B
Trailing PE: 22.3x
FWD PE *: 15.5x
Payout Ratio (TTM): 17.7%
52-Week Range: $244.82 - $377.54

* Forward PE is based on street estimates.

10 Year COR Performance Metrics:

Total Return (with DRIP): 331.7% (15.75% CAGR)
Total Return (no DRIP): 298.4% (14.82% CAGR)
Share Price: 271.9% (14.04% CAGR)
Yield on Cost (with DRIP): 3.45%
Total Invested: $10,000
Total Value (with DRIP): $43,171
Total Return $ (with DRIP): $33,171
Dividend Increase: 64.4% (5.10% CAGR)
Dividend Yield (FWD): 0.80% ($2.40)
COR 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
COR Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
COR Price CAGR:1Y: -3.88%2Y: 15.53%5Y: 20.25%10Y: 14.04%
COR Dividend Charts
COR - Dividends
COR Dividend CAGR:1Y: 9.09%2Y: 8.47%5Y: 6.40%10Y: 5.84%
COR - Dividend Payout Ratio
COR Dividend Payout Ratio CAGR:1Y: -2.35%2Y: -15.15%5Y: -46.94%10Y: -29.71%
COR - Dividend to Free Cash Flow Ratio
COR Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 5.12%5Y: -10.67%10Y: -27.50%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

COR Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

COR - Revenue
COR Revenue CAGR:1Y: 5.07%2Y: 6.85%5Y: 9.68%10Y: 8.68%
COR - Earnings Per Share (EPS)
COR EPS CAGR:1Y: 11.93%2Y: 27.60%5Y: 46.19%10Y: 24.51%
COR - Net Income
COR Net Income CAGR:1Y: 12.99%2Y: 26.75%5Y: 98.43%10Y: 49.29%
COR - EBITDA
COR EBITDA CAGR:1Y: 19.22%2Y: 25.15%5Y: 79.31%10Y: 42.75%
COR - Free Cash Flow
COR Free Cash Flow CAGR:1Y: 0.00%2Y: 1.44%5Y: 17.46%10Y: 44.49%
COR - Free Cash Flow / Share
COR Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 2.77%5Y: 19.29%10Y: 46.73%
COR - Operating Income
COR Operating Income CAGR:1Y: 22.30%2Y: 30.90%5Y: 100.32%10Y: 48.86%
COR - Gross Profit
COR Gross Profit CAGR:1Y: 35.69%2Y: 31.48%5Y: 15.69%10Y: 13.84%
COR - Shares Outstanding
COR Shares Outstanding CAGR:1Y: -0.66%2Y: -1.54%5Y: 35.20%10Y: 19.58%
COR - Share Buybacks
COR Share Buybacks CAGR:1Y: 0.00%2Y: 34.84%5Y: 0.00%10Y: 5.48%
COR - Stock-Based Comp
COR Stock-Based Comp CAGR:1Y: 23.93%2Y: 13.82%5Y: 14.89%10Y: 5.53%
COR - Expenses
COR Expenses CAGR:1Y: 23.37%2Y: 38.48%5Y: 13.16%10Y: 5.67%
COR - Revenue by Segment
COR Revenue CAGR:1Y: 5.07%2Y: 6.85%5Y: 9.68%10Y: 8.68%
COR - Revenue by Region
COR Revenue CAGR:1Y: 5.07%2Y: 6.85%5Y: 9.68%10Y: 8.68%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

COR - REVENUE: Actual + Estimates
COR Actual Revenue CAGR:1Y: 5.07%2Y: 6.85%5Y: 9.68%10Y: 8.68%
COR - EPS: Actual + Estimates
COR Actual EPS CAGR:1Y: 11.93%2Y: 27.60%5Y: 46.19%10Y: 24.51%
COR - NET INCOME: Actual + Estimates
COR Actual Net Income CAGR:1Y: 12.99%2Y: 26.75%5Y: 98.43%10Y: 49.29%
COR - EBITDA: Actual + Estimates
COR Actual EBITDA CAGR:1Y: 19.22%2Y: 25.15%5Y: 79.31%10Y: 42.75%

Ratios, Profit Margins & Return on Capital:

COR - Net Profit Margin
COR Net Profit Margin CAGR:1Y: 5.88%2Y: 17.67%5Y: 78.26%10Y: 36.53%
COR - Gross Profit Margin
COR Gross Profit Margin CAGR:1Y: 29.09%2Y: 23.13%5Y: 5.50%10Y: 4.74%
COR - Price to Earnings
COR Price to Earnings CAGR:1Y: -15.18%2Y: -11.60%5Y: -40.32%10Y: -24.96%
COR - Price To Sales Ratio
COR Price To Sales Ratio CAGR:1Y: -10.49%2Y: 3.94%5Y: 7.59%10Y: 2.90%
COR - Return on Capital Employed
COR Return on Capital Employed CAGR:1Y: -7.62%2Y: -5.50%5Y: 81.89%10Y: 31.93%
COR - Return on Invested Capital
COR Return on Invested Capital CAGR:1Y: -6.57%2Y: -3.91%5Y: 46.32%10Y: 25.64%

Compare stocks side-by-side

COR Dividends Info:

Annual Dividend: $2.4
Forward Yield: 0.8%
Ex-Dividend Date: 2026-08-14
Lifetime Dividends / Share: $25.36

COR Dividend History: Dates, Payments & Yield list

Below is a schedule of all COR dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/14/202608/31/2026$0.6000.76%0.74%$323.60
05/15/202606/01/2026$0.6000.93%0.91%$264.69
02/13/202603/02/2026$0.6000.67%0.64%$372.65
11/14/202512/01/2025$0.6000.66%0.67%$360.12
08/15/202509/03/2025$0.5500.75%0.75%$295.14
05/16/202506/02/2025$0.5500.76%0.75%$292.07
02/14/202503/03/2025$0.5500.91%0.86%$255.38
11/15/202411/29/2024$0.5500.92%0.87%$251.55
08/09/202408/26/2024$0.5100.86%0.87%$234.44
05/09/202405/24/2024$0.5100.91%0.93%$218.89
02/08/202402/26/2024$0.5100.89%0.86%$238.34
11/10/202311/27/2023$0.5101.03%1.01%$201.78
08/10/202308/28/2023$0.4851.04%1.08%$180.39
05/11/202305/30/2023$0.4851.13%1.17%$166.01
02/09/202302/27/2023$0.4851.25%1.24%$156.63
11/10/202211/28/2022$0.4851.25%1.16%$167.17
08/12/202208/29/2022$0.4601.22%1.25%$147.49
05/13/202205/31/2022$0.4601.2%1.19%$154.79
02/11/202202/28/2022$0.4601.31%1.29%$142.53
11/12/202110/15/2021$0.4601.47%1.54%$119.86
08/13/202107/15/2021$0.4401.47%1.56%$113.16
05/14/202104/15/2021$0.4401.51%1.48%$119.04
02/11/202101/15/2021$0.4401.68%1.65%$106.80
11/13/202010/15/2020$0.4401.63%1.77%$99.35
08/14/202007/15/2020$0.4201.62%1.65%$101.90
05/15/202004/15/2020$0.4201.96%1.9%$88.33
02/13/202001/15/2020$0.4201.78%1.84%$91.37
11/15/201912/02/2019$0.4001.83%1.82%$87.83
08/16/201910/15/2019$0.4001.83%1.92%$83.20
05/17/201907/15/2019$0.4002.06%1.78%$89.93
02/15/201904/15/2019$0.4001.85%2.1%$76.11
11/16/201801/15/2019$0.4001.8%2.07%$77.26
08/17/201810/15/2018$0.3801.73%1.7%$89.54
05/18/201807/16/2018$0.3801.79%1.75%$86.90
02/16/201804/16/2018$0.3801.53%1.71%$88.77
11/17/201701/16/2018$0.3801.93%1.53%$99.55
08/17/201710/16/2017$0.3651.83%1.85%$79.00
05/18/201707/17/2017$0.3651.68%1.57%$92.71
02/16/201704/17/2017$0.3651.62%1.69%$86.64
11/17/201601/17/2017$0.3651.82%1.7%$85.99
08/18/201610/17/2016$0.3401.53%1.71%$79.74
05/19/201607/15/2016$0.3401.81%1.59%$85.55
02/18/201604/15/2016$0.3401.57%1.55%$87.83
11/12/201510/15/2015$0.3401.4%1.45%$94.07
08/13/201509/01/2015$0.2901.12%1.17%$99.27
05/14/201507/15/2015$0.2901.01%1.05%$110.53
02/12/201501/15/2015$0.2901.16%1.27%$91.40
11/13/201412/01/2014$0.2901.3%1.28%$90.84
08/14/201410/15/2014$0.2351.23%1.24%$76.02
05/15/201407/15/2014$0.2351.39%1.29%$72.70
02/13/201404/15/2014$0.2351.38%1.46%$64.22
11/14/201301/15/2014$0.2351.36%1.33%$70.55
08/15/201310/15/2013$0.2101.47%1.34%$62.81
05/16/201307/15/2013$0.2101.54%1.44%$58.24
02/13/201304/15/2013$0.2101.8%1.55%$54.04
11/15/201201/15/2013$0.2102.09%1.86%$45.07
08/17/201210/15/2012$0.1301.39%1.3%$39.91
05/17/201207/16/2012$0.1301.43%1.32%$39.41
02/15/201204/16/2012$0.1301.42%1.39%$37.48
11/17/201101/17/2012$0.1301.39%1.36%$38.30
08/18/201110/17/2011$0.1151.22%1.21%$37.89
05/20/201107/15/2011$0.1151.11%1.1%$41.99
02/16/201104/15/2011$0.1301.43%1.31%$39.59
11/18/201001/14/2011$0.1301.65%1.47%$35.43
08/20/201008/25/2010$0.0801.11%1.15%$27.92
05/20/201005/24/2010$0.0801.04%1.04%$30.70
02/10/201002/12/2010$0.0801.18%1.17%$27.35
11/19/200911/23/2009$0.0801.32%1.28%$24.97
08/20/200908/24/2009$0.0601.14%1.15%$20.80
05/14/200905/18/2009$0.0501.12%1.12%$17.79
02/12/200902/16/2009$0.0501.06%1.1%$18.11
11/20/200811/24/2008$0.0501.46%1.34%$14.89
08/14/200808/18/2008$0.0380.71%0.72%$20.82
05/15/200805/19/2008$0.0380.73%0.72%$20.76
02/13/200802/15/2008$0.0380.68%0.69%$21.81
11/15/200711/19/2007$0.0380.68%0.69%$21.84
08/16/200708/20/2007$0.0250.45%0.43%$23.04
08/01/200708/03/2007$0.69912.11%12.12%$23.05
05/17/200705/21/2007$0.0250.39%0.39%$25.84
02/23/200702/28/2007$0.0250.36%0.38%$26.30
11/16/200611/20/2006$0.0250.42%0.43%$23.13
08/17/200608/21/2006$0.0130.23%0.23%$21.84
05/18/200605/22/2006$0.0130.23%0.23%$21.81
02/15/200602/17/2006$0.0130.23%0.23%$21.99
11/22/200511/24/2005$0.0130.25%0.25%$19.85
08/18/200508/22/2005$0.0060.14%0.14%$18.17
05/19/200505/23/2005$0.0060.15%0.15%$16.50
02/16/200502/18/2005$0.0060.16%0.17%$15.00
11/18/200411/22/2004$0.0060.17%0.17%$14.45
08/19/200408/23/2004$0.0060.19%0.19%$13.30
05/14/200405/19/2004$0.0060.17%0.17%$14.62
02/11/200402/13/2004$0.0060.18%0.18%$14.15
11/13/200311/17/2003$0.0060.15%0.15%$16.20
08/14/200308/18/2003$0.0060.16%0.16%$15.32
05/15/200305/19/2003$0.0060.16%0.17%$14.77
02/12/200302/14/2003$0.0060.18%0.19%$13.25
11/14/200211/18/2002$0.0060.16%0.16%$15.85
08/15/200208/19/2002$0.0060.14%0.14%$17.30
05/16/200205/20/2002$0.0060.13%0.13%$19.33
02/19/200202/21/2002$0.0060.16%0.15%$16.13
11/15/200111/19/2001$0.0060.18%0.17%$14.41

Projected Future Returns & Dividends for COR

Based on past 10-year performance, here are COR growth metrics:

Share price CAGR of +14.04%
Dividend CAGR of +5.84%

Using COR CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

COR (DRIP)COR - No DRIP
Current Price$300.40$300.40
Start Shares33.2933.29
Start Value$10,000$10,000
  
After 10 years:
Final Share Count35.2933.29
Dividends Payment$1.06$1.06
Annual Dividends$149$141
Yield on cost1.49%1.41%
Share Price$1,117.11$1,117.11
Total Dividends$1,082$1,045
Final Value$39,424$38,233

Estimated Future Value + Dividends - COR

NOTE: Above numbers are our estimate based on COR's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Cencora, Inc. (COR) had its IPO on 1995-04-04, and is traded on NYSE stock exchange.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

COR website: https://www.cencora.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — COR

Value from:
Pay up to today
—
vs current price $300.40
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →